VipStockReports

Market Movers - Viacom, Inc. (NASDAQ:VIAB), CME Group Inc (NASDAQ:CME), Cirrus Logic, Inc. (NASDAQ:CRUS), Celgene Corporation (NASDAQ:CELG)

 
Repost This

Middletown, DE -- (SBWIRE) -- 08/14/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Viacom, Inc. (NASDAQ:VIAB), CME Group Inc (NASDAQ:CME), Cirrus Logic, Inc. (NASDAQ:CRUS), Celgene Corporation (NASDAQ:CELG)

Viacom, Inc. (NASDAQ:VIAB) closed at the price of $79.74, after opening at $79.94. During the previous session, the company’s minimum price was $79.43, while it touched its highest price for the day at $80.48. VIAB’s beta value stands at 1.24 points, while its earnings per share was $4.45. Viacom Inc. operates as an entertainment content company in the United States and internationally. The company connects with audiences through compelling content on television, motion picture, online, and mobile platforms. It operates in two segments, Media Networks and Filmed Entertainment.

For How Long VIAB will Fight for Profitability? Read This Trend Analysis report

CME Group Inc (NASDAQ:CME) reported the increase of 4.04%, to close at $74.44. Its market capitalization was $24.89 billion. Its beta value stands at 1.09 times and CME Group Company’s earnings per share was $2.80. CME Group Inc. operates the CME, CBOT, NYMEX COMEX, and KCBT futures exchanges worldwide. It operates CBOT exchange, a marketplace for trading agricultural and the U.S. treasury futures, as well as options on futures.

For How Long CME’s Gloss will Attract Investors? Find out via this report

Cirrus Logic, Inc. (NASDAQ:CRUS) stock on Tuesday increased 3.79% and finished the day at $21.11. The 52 week range of the stock remained $16.46 - $45.49. CRUS’s beta value stands at 0.58 points, while its earnings per share was $2.20. Cirrus Logic, Inc., a fabless semiconductor company, develops analog and mixed-signal integrated circuits (ICs) for a range of consumer and industrial markets. The company offers audio products, including analog-to-digital converters (ADCs), digital-to-analog converters (DACs), codecs, digital interface ICs, volume controls, adaptive noise cancelling circuits, and amplifiers.

Will CRUS Continue To Move Higher? Find Out Here

Celgene Corporation (NASDAQ:CELG) traded with a plunge of -2.26% and closed at $137.65. Its opening price was $141.03. Celgene Corporation's earnings per share is $3.58, while its beta value stands at 0.80 times. CELG has total market capitalization of $56.60 billion and a total of 411.20 million outstanding shares. Celgene Corporation discovers, develops, and commercializes therapies for cancer and immune-inflammatory related diseases in the United States and Europe. Its commercial stage products include REVLIMID, a drug to treat multiple myeloma and transfusion-dependent anemia.

Will CELG Get Buyers Even After The Recent Rally? Find Out Here

About VipStockReports.com:
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!

Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.

Disclaimer:
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.

VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.

Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/